Reply letter to Almasi-Hashiana A et al.
We thank Almasi-Hashiana et al. for their interest in and constructive comments on our study investigating the factors associated with seroreversion of anti-hepatitis A antibodies among HIV-positive patients who had completed 2 doses of hepatitis A vaccination with documented serconversion. In an infectious disease outbreak, the risk of exposure to the infectious agent may evolve with time and location. Thus, these factors were likely to become strong confounders for the outcome of seroreversion in this study. The purpose of the matching in the case-control analysis of our study was to mitigate the confounding effects.